vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and ONTO INNOVATION INC. (ONTO). Click either name above to swap in a different company.
ONTO INNOVATION INC. is the larger business by last-quarter revenue ($218.2M vs $123.8M, roughly 1.8× NATURES SUNSHINE PRODUCTS INC). ONTO INNOVATION INC. runs the higher net margin — 12.9% vs 3.3%, a 9.6% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -13.5%). ONTO INNOVATION INC. produced more free cash flow last quarter ($82.0M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 2.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Onto Innovation Inc. is an American semiconductor company formed in 2019 from the merger of Rudolph Technologies, Inc. and Nanometrics Incorporated. It is a provider of process and process control equipment and software for microelectronic manufacturing industries.
NATR vs ONTO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $218.2M |
| Net Profit | $4.1M | $28.2M |
| Gross Margin | 72.5% | 50.7% |
| Operating Margin | 4.3% | 10.9% |
| Net Margin | 3.3% | 12.9% |
| Revenue YoY | 4.7% | -13.5% |
| Net Profit YoY | 1379.4% | -46.8% |
| EPS (diluted) | $0.23 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | — | ||
| Q3 25 | $128.3M | $218.2M | ||
| Q2 25 | $114.8M | $253.6M | ||
| Q1 25 | $113.2M | $266.6M | ||
| Q4 24 | $118.2M | $263.9M | ||
| Q3 24 | $114.6M | $252.2M | ||
| Q2 24 | $110.6M | $242.3M | ||
| Q1 24 | $111.0M | $228.8M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $28.2M | ||
| Q2 25 | $5.3M | $33.9M | ||
| Q1 25 | $4.7M | $64.1M | ||
| Q4 24 | $-321.0K | $48.8M | ||
| Q3 24 | $4.3M | $53.1M | ||
| Q2 24 | $1.3M | $52.9M | ||
| Q1 24 | $2.3M | $46.9M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | 50.7% | ||
| Q2 25 | 71.7% | 48.2% | ||
| Q1 25 | 72.1% | 53.7% | ||
| Q4 24 | 72.0% | 50.2% | ||
| Q3 24 | 71.3% | 54.1% | ||
| Q2 24 | 71.4% | 52.9% | ||
| Q1 24 | 71.2% | 51.7% |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 7.0% | 10.9% | ||
| Q2 25 | 3.7% | 12.7% | ||
| Q1 25 | 5.4% | 23.7% | ||
| Q4 24 | 3.8% | 16.1% | ||
| Q3 24 | 4.6% | 21.0% | ||
| Q2 24 | 5.1% | 20.2% | ||
| Q1 24 | 4.2% | 18.7% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 12.9% | ||
| Q2 25 | 4.6% | 13.4% | ||
| Q1 25 | 4.2% | 24.0% | ||
| Q4 24 | -0.3% | 18.5% | ||
| Q3 24 | 3.8% | 21.0% | ||
| Q2 24 | 1.2% | 21.9% | ||
| Q1 24 | 2.1% | 20.5% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | $0.57 | ||
| Q2 25 | $0.28 | $0.69 | ||
| Q1 25 | $0.25 | $1.30 | ||
| Q4 24 | $-0.02 | $0.98 | ||
| Q3 24 | $0.23 | $1.07 | ||
| Q2 24 | $0.07 | $1.07 | ||
| Q1 24 | $0.12 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $603.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $2.0B |
| Total Assets | $261.1M | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | $603.1M | ||
| Q2 25 | $81.3M | $217.5M | ||
| Q1 25 | $86.5M | $203.7M | ||
| Q4 24 | $84.7M | $212.9M | ||
| Q3 24 | $78.7M | $188.7M | ||
| Q2 24 | $68.7M | $172.6M | ||
| Q1 24 | $77.8M | $190.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | — | ||
| Q3 25 | $166.7M | $2.0B | ||
| Q2 25 | $163.7M | $2.0B | ||
| Q1 25 | $167.1M | $1.9B | ||
| Q4 24 | $161.0M | $1.9B | ||
| Q3 24 | $162.6M | $1.9B | ||
| Q2 24 | $156.4M | $1.8B | ||
| Q1 24 | $159.7M | $1.8B |
| Q4 25 | $261.1M | — | ||
| Q3 25 | $264.8M | $2.2B | ||
| Q2 25 | $254.9M | $2.1B | ||
| Q1 25 | $252.7M | $2.1B | ||
| Q4 24 | $240.9M | $2.1B | ||
| Q3 24 | $245.3M | $2.1B | ||
| Q2 24 | $235.8M | $2.0B | ||
| Q1 24 | $247.3M | $2.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $83.4M |
| Free Cash FlowOCF − Capex | $7.6M | $82.0M |
| FCF MarginFCF / Revenue | 6.1% | 37.6% |
| Capex IntensityCapex / Revenue | 1.9% | 0.6% |
| Cash ConversionOCF / Net Profit | 2.41× | 2.95× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $261.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | — | ||
| Q3 25 | $18.5M | $83.4M | ||
| Q2 25 | $4.3M | $57.9M | ||
| Q1 25 | $2.6M | $92.0M | ||
| Q4 24 | $12.2M | $56.0M | ||
| Q3 24 | $9.6M | $67.2M | ||
| Q2 24 | $1.3M | $65.3M | ||
| Q1 24 | $2.2M | $57.1M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | $82.0M | ||
| Q2 25 | $3.0M | $44.2M | ||
| Q1 25 | $1.5M | $83.7M | ||
| Q4 24 | $10.0M | $51.4M | ||
| Q3 24 | $7.9M | $59.2M | ||
| Q2 24 | $-2.0M | $53.0M | ||
| Q1 24 | $-1.5M | $50.2M |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | 37.6% | ||
| Q2 25 | 2.6% | 17.4% | ||
| Q1 25 | 1.3% | 31.4% | ||
| Q4 24 | 8.5% | 19.5% | ||
| Q3 24 | 6.9% | 23.5% | ||
| Q2 24 | -1.9% | 21.9% | ||
| Q1 24 | -1.4% | 21.9% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 1.2% | 5.4% | ||
| Q1 25 | 1.0% | 3.1% | ||
| Q4 24 | 1.9% | 1.8% | ||
| Q3 24 | 1.5% | 3.2% | ||
| Q2 24 | 3.0% | 5.1% | ||
| Q1 24 | 3.3% | 3.0% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 2.95× | ||
| Q2 25 | 0.81× | 1.71× | ||
| Q1 25 | 0.55× | 1.44× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | 2.21× | 1.27× | ||
| Q2 24 | 0.97× | 1.23× | ||
| Q1 24 | 0.94× | 1.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
ONTO
| Systems And Software Revenue | $173.8M | 80% |
| Parts Revenue | $23.9M | 11% |
| Service Revenue | $20.5M | 9% |
